https://orcid.org/0000-0002-9023-581X
Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jamie Findlow, Ray Borrow, David S. Stephens, Paul Liberator, Annaliesa S. Anderson, Paul Balmer & Luis Jodar. (2022) Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverage. Expert Review of Vaccines 21:6, pages 753-769.
Read now
Read now
Ala-Eddine Deghmane & Muhamed-Kheir Taha. (2022) Product review on the IMD serogroup B vaccine Bexsero®. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
YongLi Hou, Ting Yan, Hui Cao, Peng Liu, Kang Zheng, Zhenyu Li, Qing Deng & SiHai Hu. (2019) Chimeric hepatitis B virus core particles displaying Neisserial surface protein A confer protection against virulent Neisseria meningitidis serogroup B in BALB/c mice. International Journal of Nanomedicine 14, pages 6601-6613.
Read now
Read now
Irene Rivero-Calle, Peter Francis Raguindin, Jose Gómez-Rial, Carmen Rodriguez-Tenreiro & Federico Martinón-Torres. (2019) Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B. Infection and Drug Resistance 12, pages 3169-3188.
Read now
Read now
Articles from other publishers (10)
George Kassianos, Osamah Barasheed, Victoria Abbing-Karahagopian, Mansour Khalaf, Serdar Ozturk, Angelika Banzhoff & Selim Badur. (2023) Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review. Infectious Diseases and Therapy 12:9, pages 2193-2219.
Crossref
Crossref
Lorenzo Lodi, Federica Barbati, Daniela Amicizia, Vincenzo Baldo, Anna Maria Barbui, Alessandro Bondi, Claudio Costantino, Liviana Da Dalt, Lorenza Ferrara, Francesca Fortunato, Valentina Guarnieri, Giancarlo Icardi, Giuseppe Indolfi, Domenico Martinelli, Marco Martini, Maria Moriondo, Francesco Nieddu, Diego G. Peroni, Rosa Prato, Silvia Ricci, Francesca Russo, Francesca Tirelli, Francesco Vitale, Shamez N. Ladhani, Chiara Azzari, Mario Palermo, Girolama Bosco, Rosanna Milisenna, Mario Cuccia, Franco Belbruno, Giulia Tarabini Castellani, Claudio D’Angelo, Giuseppe Ferrera, Lia Contrino, Gaspare Canzoneri, Onofrio Mongelli, Nehludoff Albano, Domenico Lagravinese, Riccardo Matera, Stefano Termite, Giovanni Iannucci, Alberto Fedele, Michele Conversano, Irene Amoruso, Tatjana Baldovin, Silvia Cocchio, Nicole Bonaccorso, Martina Sciortino, Arianna Conforto, Susanna Masiero, Daniela Lombardi, Elisa Di Maggio, Martina Meola, Silvia Boscia, Michele Tonon, Marzio Masini, Maria Francesca Piazza & Camilla Sticchi. (2023) Four-Component Recombinant Protein–Based Vaccine Effectiveness Against Serogroup B Meningococcal Disease in Italy. JAMA Network Open 6:8, pages e2329678.
Crossref
Crossref
Markus Knuf. (2023) Was gibt es Neues bei der Meningokokken- und Pneumokokken-Impfung?. Kinder- und Jugendmedizin 23:03, pages 165-180.
Crossref
Crossref
Helen S Marshall, Timo Vesikari, Peter C Richmond, Jacek Wysocki, Leszek Szenborn, Johannes Beeslaar, Jason D Maguire, Paul Balmer, Robert O'Neill, Annaliesa S Anderson, Jean-Louis Prégaldien, Roger Maansson, Han-Qing Jiang & John L Perez. (2023) Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1–9 years: two phase 2 randomised, controlled, observer-blinded studies. The Lancet Infectious Diseases 23:1, pages 103-116.
Crossref
Crossref
Federico Martinón-Torres, Ángel Gil de Miguel, Jesús Ruiz-Contreras, Laura A. Vallejo-Aparicio, Andrea García, María C. Gonzalez-Inchausti, Eduardo de Gomensoro, Zeki Kocaata, Clara Gabás-Rivera, Marta Comellas, Miriam Prades & Luis Lizán. (2022) Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain. Infectious Diseases and Therapy 12:1, pages 157-175.
Crossref
Crossref
M. Knuf & T. Tenenbaum. (2021) MeningokokkenimpfstoffeMeningococcal vaccines. Monatsschrift Kinderheilkunde 169:11, pages 1034-1042.
Crossref
Crossref
M.J. Klouwens, M.L.M. Salverda, J.J. Trentelman, J.I. Ersoz, A. Wagemakers, M.J.H. Gerritzen, P.A. van der Ley & J.W. Hovius. (2021) Vaccination with meningococcal outer membrane vesicles carrying Borrelia OspA protects against experimental Lyme borreliosis. Vaccine 39:18, pages 2561-2567.
Crossref
Crossref
Alessia Biolchi, Gabriella De Angelis, Monica Moschioni, Sara Tomei, Brunella Brunelli, Maria Giuliani, Stefania Bambini, Ray Borrow, Heike Claus, Maria Cecilia O. Gorla, Eva Hong, Ana Paula S. Lemos, Jay Lucidarme, Muhamed-Kheir Taha, Ulrich Vogel, Maurizio Comanducci, Sonia Budroni, Marzia M. Giuliani, Rino Rappuoli, Mariagrazia Pizza & Philip Boucher. (2020) Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates. Vaccine 38:47, pages 7542-7550.
Crossref
Crossref
Mariagrazia Pizza, Rafik Bekkat-Berkani & Rino Rappuoli. (2020) Vaccines against Meningococcal Diseases. Microorganisms 8:10, pages 1521.
Crossref
Crossref
Catherine Isitt, Catherine A Cosgrove, Mary Elizabeth Ramsay & Shamez N Ladhani. (2020) Success of 4CMenB in preventing meningococcal disease: evidence from real-world experience. Archives of Disease in Childhood 105:8, pages 784-790.
Crossref
Crossref